Many adults are unaware of the importance of adult immunization. Most are given via injection in the upper arm, but some vaccines can be given by mouth or nasal spray. Regardless of the method, adults should receive their vaccines annually. In addition to their routine checkups, many doctors and healthcare providers recommend a series of additional immunizations for their patients. This will help prevent illnesses from occurring. And when you get a flu shot, you’ll be much more protected.
The global adult vaccines market was valued at US$ 12,806.4 million in 2021 and is projected to exhibit a CAGR of 7.1% over the forecast period (2022–2028).
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Approval and launch of new vaccines is expected to propel growth of the global adult vaccines market over the forecast period. For instance, in July 2017, Pfizer, Inc. introduced its Meningitis B jab TRUMENBA in the U.K. for adults aged 18-25 years.
Moreover, high prevalence of influenza is also expected to propel growth of the global adult vaccines market over the forecast period. For instance, according to the Centers of Disease Control & Prevention (CDC) 2013, around 226,000 patients are hospitalized each year due to influenza and its complications, out of which around 3000-4000 patients die due to the disease.
R&D of new vaccines is expected to offer lucrative growth opportunities for players in the global adult vaccines market. For instance, in January 2018, Bharat Biotech, in collaboration with Typhoid Vaccine Acceleration Consortium, received pre-qualification for its typhoid conjugate vaccine—Typbar TCV—from the World Health Organization.
Moreover, increasing awareness for vaccination is also expected to offer lucrative growth opportunities for players in the global adult vaccines market. For instance, in 2011, the World Health Organization (WHO) and a group of partners, initiated The Global Vaccine Safety Initiative to ensure that all countries have at least a minimal capacity to ensure vaccine safety.
Major players operating in the global adult vaccines market are focused on approval and launch of new vaccines to expand their product portfolio. For instance, in March 2018, Pfizer, Inc. launched TRUMENBA, a vaccine indicated for adolescents and young adults aged 18-25 years, for prevention of meningitis B, in Canada.
Ask for PDF Brochure @
Covid-19 Impact Analysis:
Globally, as of 5:14pm CET, 17 December 2021, there have been 271,963,258 confirmed cases of COVID-19, including 5,331,019 deaths, reported to WHO. Emergence of Covid-19 has led to mass vaccination worldwide. As of 16 December 2021, a total of 8,337,664,456 vaccine doses have been administered.
North America is expected to witness significant growth in the global adult vaccines market, owing to launch of new vaccines. For instance, in August 2017, Dallas County Health & Human Services (DCHHS) introduced a flu vaccine that serves to be an all-in-one shot vaccine for various flu strains including H1N1, specifically indicated for adults
Major players operating in the global adult vaccines market include, AstraZeneca Plc, CSL Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Medimmune, Pfizer, Inc., Sanofi Pasteur, and Serum Institute of India.
Market Key Developments:
Major players operating in the global adult vaccines market are focused on approval and launch of new vaccines to expand their product portfolio. For instance, in March 2018, GlaxoSmithKline Plc received approval for its Shingles vaccine—Shingrix—for adults from European Commission and Japanese Ministry of Health.
Reasons To buy The Adult Vaccines Market Report:
➛ In-depth analysis of the market on the global and regional levels.
➛ Major changes in market dynamics and competitive landscape.
➛ Segmentation on the basis of type, application, geography, and others.
➛ Historical and future market research in terms of size, share growth, volume, and sales.
➛ Major changes and assessment in market dynamics and developments.
➛ Emerging key segments and regions
➛ Key business strategies by major market players and their key methods.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Points cover in Global Adult Vaccines Market Research Report:
Chapter 1: Overview of Global Adult Vaccines Market (2022-2028)
Chapter 2: Market Competition by Players/Suppliers 2022 and 2028
- Manufacturing Cost Structure
- Manufacturing Process
- Industry Chain Structure
Chapter 3: Sales (Volume) and Revenue (Value) by Region (2022-2028)
- Revenue and market share
Chapter 4, 5 and 6: Global Adult Vaccines Market by Type, Application & Players/Suppliers Profiles (2022-2028)
- Market Share by Type & Application
- Growth Rate by Type & Application
- Drivers and Opportunities
- Company Basic Information
Chapter 7, 8 and 9: Global Adult Vaccines Manufacturing Cost, Sourcing & Marketing Strategy Analysis
- Key Raw Materials Analysis
- Upstream Raw Materials Sourcing
- Marketing Channel
Chapter 10 and 11: Adult Vaccines Market Effect Factors Analysis and Market Size (Value and Volume) Forecast (2022-2028)
- Technology Progress/Risk
- Sales Volume, Revenue Forecast (by Type, Application & Region)
Chapter 12, 13, 14 and 15: Global Adult Vaccines Market Research Findings and Conclusion, appendix and data source
- Methodology/Research Approach
- Data Source (Secondary Sources & Primary Sources)
- Market Size Estimation
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027